标题
Recent advances in anti-angiogenic nanomedicines for cancer therapy
作者
关键词
-
出版物
Nanoscale
Volume 10, Issue 12, Pages 5393-5423
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-02-12
DOI
10.1039/c7nr09612g
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs
- (2018) Raj Kumar et al. ULTRASONICS SONOCHEMISTRY
- VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)
- (2017) Fan-Wei Peng et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
- (2017) Jinliang Chen et al. International Journal of Nanomedicine
- Nanoparticles as new tools for inhibition of cancer angiogenesis
- (2017) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles
- (2017) Gijung Kwak et al. JOURNAL OF CONTROLLED RELEASE
- The Role of PDGFs and PDGFRs in Colorectal Cancer
- (2017) Roberta M. Manzat Saplacan et al. MEDIATORS OF INFLAMMATION
- Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria
- (2017) Shoukath Sulthana et al. MOLECULAR PHARMACEUTICS
- Enhanced Systemic Anti-Angiogenic siVEGF Delivery Using PEGylated Oligo-d-arginine
- (2017) Jee Young Chung et al. MOLECULAR PHARMACEUTICS
- Therapeutic targeting of the angiopoietin–TIE pathway
- (2017) Pipsa Saharinen et al. NATURE REVIEWS DRUG DISCOVERY
- Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression
- (2017) P A Guerrero et al. ONCOGENE
- Fabrication of metalosomes (metal containing cationic liposomes) using single chain surfactants as a precursor via formation of inorganic organic hybrids
- (2017) Preeti Garg et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Cyanine based Nanoprobes for Cancer Theranostics
- (2017) Pravin Bhattarai et al. Advanced Healthcare Materials
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
- (2017) Ahmed M. Al-Abd et al. Journal of Advanced Research
- Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis
- (2017) Joydeep Das et al. Scientific Reports
- Nanoceria-Mediated Drug Delivery for Targeted Photodynamic Therapy on Drug-Resistant Breast Cancer
- (2016) Hong Li et al. ACS Applied Materials & Interfaces
- LHD-Modified Mechanism-Based Liposome Coencapsulation of Mitoxantrone and Prednisolone Using Novel Lipid Bilayer Fusion for Tissue-Specific Colocalization and Synergistic Antitumor Effects
- (2016) Tingting Hu et al. ACS Applied Materials & Interfaces
- Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy
- (2016) Indranil Banerjee et al. Acta Biomaterialia
- Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor
- (2016) Hua Jin et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Inorganic Nanoparticles for Image-Guided Therapy
- (2016) Hong Yeol Yoon et al. BIOCONJUGATE CHEMISTRY
- Microwave-Triggered Smart Drug Release from Liposomes Co-encapsulating Doxorubicin and Salt for Local Combined Hyperthermia and Chemotherapy of Cancer
- (2016) Yushen Jin et al. BIOCONJUGATE CHEMISTRY
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
- (2016) Yuko Nakamura et al. BIOCONJUGATE CHEMISTRY
- Modulating Drug Release Rate from Partially Silica-Coated Bicellar Nanodisc by Incorporating PEGylated Phospholipid
- (2016) Li Lin et al. BIOCONJUGATE CHEMISTRY
- Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application
- (2016) Pei-Xin Lai et al. BIOMATERIALS
- Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy
- (2016) Jinhwan Kim et al. BIOMATERIALS
- Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
- (2016) Miriana Hijaz et al. BMC CANCER
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasivenessviaEGFR/VEGFR-2-mediated pathway in breast cancer
- (2016) S. Balakrishnan et al. CELL PROLIFERATION
- Combinatorial Polymeric Conjugated Micelles with Dual Cytotoxic and Antiangiogenic Effects for the Treatment of Ovarian Cancer
- (2016) Deepa A. Rao et al. CHEMISTRY OF MATERIALS
- Functional role of inorganic trace elements in angiogenesis part III: (Ti, Li, Ce, As, Hg, Va, Nb and Pb)
- (2016) Mohammad Ali Saghiri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy
- (2016) Ralph D. Sanderson et al. FEBS Journal
- Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis
- (2016) Tieshan Yang et al. International Journal of Nanomedicine
- Carbon nanotubes as cancer therapeutic carriers and mediators
- (2016) Kuk Hui Son et al. International Journal of Nanomedicine
- Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors
- (2016) Golam Kibria et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma
- (2016) Cong Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Rapamycin/DiR loaded lipid-polyaniline nanoparticles for dual-modal imaging guided enhanced photothermal and antiangiogenic combination therapy
- (2016) Jinping Wang et al. JOURNAL OF CONTROLLED RELEASE
- Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Jonathan A Ledermann et al. LANCET
- Insight into the Modification of Polymeric Micellar and Liposomal Nanocarriers by Fluorescein-Labeled Lipids and Uptake-Mediating Lipopeptides
- (2016) Sören Draffehn et al. LANGMUIR
- Amine functionalised hydroxyapatite nanoparticles for anti-angiogenesis gene therapy of breast cancer
- (2016) Hongjie Xu et al. Micro & Nano Letters
- Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
- (2016) Bruce A. Corliss et al. MICROCIRCULATION
- RGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathway
- (2016) Xiaoyan Fu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Ten years of anti-vascular endothelial growth factor therapy
- (2016) Napoleone Ferrara et al. NATURE REVIEWS DRUG DISCOVERY
- Co-Delivery of angiostatin and curcumin by a biodegradable polymersome for antiangiogenic therapy
- (2016) Yue Cao et al. RSC Advances
- Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
- (2016) Wei Li et al. Scientific Reports
- Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
- (2016) Hang Xing et al. Theranostics
- The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis
- (2016) W. Liang et al. Cancer Immunology Research
- Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery
- (2016) Domenico Lombardo et al. Nanomaterials
- Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
- (2016) O Jung et al. Oncogenesis
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia
- (2015) Manli Song et al. ACS Nano
- Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake
- (2015) Beatriz Pelaz et al. ACS Nano
- Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
- (2015) Thomas Condamine et al. Annual Review of Medicine
- Selenium compounds as therapeutic agents in cancer
- (2015) Aristi P. Fernandes et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Design of Cationic Multiwalled Carbon Nanotubes as Efficient siRNA Vectors for Lung Cancer Xenograft Eradication
- (2015) Chang Guo et al. BIOCONJUGATE CHEMISTRY
- VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo
- (2015) Sixiang Shi et al. BIOMATERIALS
- Endothelial Cell Metabolism in Normal and Diseased Vasculature
- (2015) Guy Eelen et al. CIRCULATION RESEARCH
- Anti-angiogenic alternatives to VEGF blockade
- (2015) Kabir A. Khan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting FGFR Signaling in Cancer
- (2015) M. Touat et al. CLINICAL CANCER RESEARCH
- Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer
- (2015) Ravi Doddapaneni et al. DRUG DELIVERY
- Lipid-based nanocarriers for breast cancer treatment – comprehensive review
- (2015) Siddartha Venkata Talluri et al. DRUG DELIVERY
- Silver nanoparticles: synthesis, properties, and therapeutic applications
- (2015) Liuya Wei et al. DRUG DISCOVERY TODAY
- Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics
- (2015) Jennifer Arrondeau et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Global health from a cancer care perspective
- (2015) Madeline Pesec et al. Future Oncology
- Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art
- (2015) Mohammad Zaki Ahmad et al. JOURNAL OF DRUG TARGETING
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Fatty acid carbon is essential for dNTP synthesis in endothelial cells
- (2015) Sandra Schoors et al. NATURE
- Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma
- (2015) Ulrik Lassen et al. NEURO-ONCOLOGY
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- Graphene Oxides Show Angiogenic Properties
- (2015) Sudip Mukherjee et al. Advanced Healthcare Materials
- Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation
- (2015) Dorota Bartczak et al. Biomaterials Science
- Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3Integrin and VEGF Receptors
- (2015) Simone Zanella et al. ChemistryOpen
- Endothelial PFKFB3 Plays a Critical Role in Angiogenesis
- (2014) Yiming Xu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas
- (2014) Zhen-Zhen Yang et al. BIOMATERIALS
- Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis
- (2014) Ying-Yun Guan et al. BIOMATERIALS
- Redox-responsive polyanhydride micelles for cancer therapy
- (2014) Jie Wang et al. BIOMATERIALS
- Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials
- (2014) Elham Fakhrejahani et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs
- (2014) Gayong Shim et al. JOURNAL OF CONTROLLED RELEASE
- Controlled drug delivery systems: Past forward and future back
- (2014) Kinam Park JOURNAL OF CONTROLLED RELEASE
- Surface Engineered Dendrimers as Antiangiogenic Agent and Carrier for Anticancer Drug: Dual Attack on Cancer
- (2014) K. Jain et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- (2014) Edward B Garon et al. LANCET
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Anti-Angiogenesis Effect of Biogenic Silver Nanoparticles Synthesized Using Saliva officinalis on Chick Chorioalantoic Membrane (CAM)
- (2014) Javad Baharara et al. MOLECULES
- The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging
- (2014) Qianqian Yu et al. Nanoscale
- Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
- (2014) Roman L. Bogorad et al. Nature Communications
- Multidisciplinary Efforts Driving Translational Theranostics
- (2014) Tony Y. Hu Theranostics
- Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling Blockade
- (2014) Nicolò Rigamonti et al. Cell Reports
- The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics
- (2014) Edward Hammond et al. Frontiers in Oncology
- Manipulation of in Vitro Angiogenesis Using Peptide-Coated Gold Nanoparticles
- (2013) Dorota Bartczak et al. ACS Nano
- Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis
- (2013) Shixian Huang et al. ACS Nano
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti-angiogenic activity of heparin functionalised cerium oxide nanoparticles
- (2013) Megan S. Lord et al. BIOMATERIALS
- Tumor vasculature targeting and imaging in living mice with reduced graphene oxide
- (2013) Sixiang Shi et al. BIOMATERIALS
- Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles
- (2013) Dongdong Sun et al. BIOMATERIALS
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
- (2013) Sandra Schoors et al. Cell Metabolism
- Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease
- (2013) Claire M. Weekley et al. CHEMICAL SOCIETY REVIEWS
- Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube–polymer interactions
- (2013) Mohsen Adeli et al. CHEMICAL SOCIETY REVIEWS
- Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
- (2013) Y. Kienast et al. CLINICAL CANCER RESEARCH
- Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
- (2013) Kunn Hadinoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Angiopoietin signaling in the vasculature
- (2013) Lauri Eklund et al. EXPERIMENTAL CELL RESEARCH
- Preparation of Curcumin-Loaded Poly(ester amine) Nanoparticles for the Treatment of Anti-Angiogenesis
- (2013) Qiuxia Ding et al. Journal of Biomedical Nanotechnology
- Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
- (2013) Alfredo Carrato et al. JOURNAL OF CLINICAL ONCOLOGY
- RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system
- (2013) Yu Sakurai et al. JOURNAL OF CONTROLLED RELEASE
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Cerium oxide nanoparticles: applications and prospects in nanomedicine
- (2013) Soumen Das et al. Nanomedicine
- Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression
- (2013) Hongyuan Song et al. Nanoscale
- Applications of inorganic nanoparticles as therapeutic agents
- (2013) Taeho Kim et al. NANOTECHNOLOGY
- A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals
- (2013) Yiguang Wang et al. NATURE MATERIALS
- Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
- (2013) Shailendra Giri et al. PLoS One
- Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
- (2013) Yihai Cao TRENDS IN MOLECULAR MEDICINE
- Optimized siRNA-PEG Conjugates for Extended Blood Circulation and Reduced Urine Excretion in Mice
- (2013) Frank Iversen et al. Theranostics
- The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway
- (2013) G. Thurston et al. Cold Spring Harbor Perspectives in Medicine
- Anti-VEGF Therapies in the Clinic
- (2013) K. L. Meadows et al. Cold Spring Harbor Perspectives in Medicine
- Comparison of anti-angiogenic properties of pristine carbon nanoparticles
- (2013) Mateusz Wierzbicki et al. Nanoscale Research Letters
- Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance
- (2012) Alexander Levitzki Annual Review of Pharmacology and Toxicology
- Reprint of “Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells”
- (2012) Napoleone Ferrara BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles
- (2012) Changyang Gong et al. BIOMATERIALS
- The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling
- (2012) Dongdong Sun et al. BIOMATERIALS
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
- (2012) Rochelle R. Arvizo et al. CHEMICAL SOCIETY REVIEWS
- The discovery of placenta growth factor and its biological activity
- (2012) Sandro De Falco EXPERIMENTAL AND MOLECULAR MEDICINE
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
- (2012) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- Amphiphilic poly(l-amino acids) — New materials for drug delivery
- (2012) Aikaterini Lalatsa et al. JOURNAL OF CONTROLLED RELEASE
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- Ziv-aflibercept: binding to more than VEGF-A—does more matter?
- (2012) Jeffrey M. Clarke et al. Nature Reviews Clinical Oncology
- Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
- (2011) Anat Eldar-Boock et al. BIOMATERIALS
- PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
- (2011) K Dredge et al. BRITISH JOURNAL OF CANCER
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
- (2011) Nicholas J. Robert et al. Clinical Breast Cancer
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
- (2011) Joseph P. Ritchie et al. CLINICAL CANCER RESEARCH
- Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1
- (2011) Tomasz Zygmunt et al. DEVELOPMENTAL CELL
- Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism
- (2011) J. Kim et al. GENES & DEVELOPMENT
- Cancer stem cells and angiogenesis
- (2011) Yue Zhao et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery
- (2011) Tatsuaki Tagami et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2011) Adam M. Brufsky et al. JOURNAL OF CLINICAL ONCOLOGY
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Chitosan/VEGF-sIRNA nanoparticle for gene silencing
- (2011) Yan Yang et al. JOURNAL OF CONTROLLED RELEASE
- Liposome based systems for systemic siRNA delivery: Stability in blood sets the requirements for optimal carrier design
- (2011) Kevin Buyens et al. JOURNAL OF CONTROLLED RELEASE
- Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
- (2011) Mark R. Gilbert et al. JOURNAL OF NEURO-ONCOLOGY
- Reactive Oxygen Species Driven Angiogenesis by Inorganic Nanorods
- (2011) Chitta Ranjan Patra et al. NANO LETTERS
- Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
- (2011) Rochelle R. Arvizo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis
- (2011) He Zhou et al. PLoS One
- VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
- (2011) Pipsa Saharinen et al. TRENDS IN MOLECULAR MEDICINE
- Delivery of siRNA Therapeutics: Barriers and Carriers
- (2010) Jie Wang et al. AAPS Journal
- Shape Effect of Carbon Nanovectors on Angiogenesis
- (2010) Padmaparna Chaudhuri et al. ACS Nano
- PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
- (2010) Carlos Bais et al. CELL
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
- (2010) Napoleone Ferrara NATURE MEDICINE
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
- (2009) Beverly L. Falcón et al. AMERICAN JOURNAL OF PATHOLOGY
- Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis
- (2009) Rania Harfouche et al. ANGIOGENESIS
- Antiangiogenic properties of silver nanoparticles
- (2009) Sangiliyandi Gurunathan et al. BIOMATERIALS
- Arterial–Venous Specification During Development
- (2009) Matthew R. Swift et al. CIRCULATION RESEARCH
- Synergistic Targeting of αvβ3Integrin and Galectin-1 with Heteromultivalent Paramagnetic Liposomes for Combined MR Imaging and Treatment of Angiogenesis
- (2009) Ewelina Kluza et al. NANO LETTERS
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Heparanase induces VEGF C and facilitates tumor lymphangiogenesis
- (2008) Victoria Cohen-Kaplan et al. INTERNATIONAL JOURNAL OF CANCER
- Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
- (2008) Anurag Purushothaman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model
- (2008) Amr Abu-Lila et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Differential function of Tie2 at cell–cell contacts and cell–substratum contacts regulated by angiopoietin-1
- (2008) Shigetomo Fukuhara et al. NATURE CELL BIOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Notch signaling regulates tumor angiogenesis by diverse mechanisms
- (2008) J Dufraine et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now